United States · Platforms & data · Yahoo Finance

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

Published by Yahoo Finance · United States 8 h ago

Pfizer (NYSE:PFE) signed a new research collaboration and license agreement with Enodia Therapeutics to develop Sec61 inhibitors. The arrangement centers on small-molecule Sec61…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

MarketBeat

Financial Institutions (FISI) Set to Release Quarterly Earnings on Thursday

Seeking Alpha

IBM expects 2026 revenue growth of 4% to 5% while raising free cash flow growth view to more than $1B

The Motley Fool

Is This Cryptocurrency a Potential Millionaire-Maker?

MarketWatch

My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now?

Investing.com

Nokia reports 9% Q3 sales growth, raises restructuring costs

Stocktwits